Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni

Immunobiology

Volumn 214, Issue 8, 2009, Pages 712-727

  Allam, Gamal ^a,b  

^a Beni Suef University   (Egypt)

^b TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

Antibody; Curcumin; Cytokine; Immunomodulation; Schistosoma mansoni

Indexed keywords

ANTIGEN; CATALASE; CURCUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12; LIVER ENZYME; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME ACTIVITY; EOSINOPHILIA; GRANULOMATOUS INFLAMMATION; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOMODULATION; IN VIVO STUDY; LEUKOCYTE COUNT; LIVER DISEASE; LIVER GRANULOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS MANSONI;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CATALASE; CURCUMA; CURCUMIN; CYTOKINES; GRANULOMA; HELMINTH PROTEINS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; LIVER; MALE; MICE; PARASITE EGG COUNT; PHYTOTHERAPY; PLANT ROOTS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 67650033100     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.11.017     Document Type: Article

References (145)

1. Abe Y., Hashimoto S., and Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res. 39 (1999) 41-47
2. Aggarwal B.B., and Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 41 (2009) 40-59
3. Aggarwal B.B., Kumar A., and Bharti A.C. Anticancer potential of curcumin, preclinical and clinical studies. Anticancer Res. 23 (2003) 363-398
4. Allam G. Vasoactive intestinal peptide inhibits liver pathology in acute murine Schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-α production. Immunobiology 212 (2007) 603-612
5. Allam G., and Ahmed O.M. Does Salamonella typhimurium lipopolysaccharide have prophylactic potentials against murine schistosomiasis mansoni?. Egypt J. Zool. 45 (2005) 389-408
6. Amiri P., Locksley R.M., Parslow T.G., Sadick M., Rector E., Ritter D., and McKerrow J.H. Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 356 (1992) 604-607
7. Araújo C.A.C., and Leon L.L. Biological activities of Curcuma longa L. Mem. Inst. Oswaldo Cruz 96 (2001) 723-728
8. Araújo C.A.C., Alegrio L.V., Castro D., Lima M.E.F., and Leon L.L. Leishmania amazonensis, in vivo experiments with diarylheptanoids from Leguminosae and Zingiberaceae plants. Mem. Inst. Oswaldo Cruz 93 (1998) 306
9. Araújo C.A.C., Alegrio L.V., Castro D., Lima M.E.F., Gomes-Cardoso L., and Leon L.L. Studies on the effectiveness of diarylheptanoids derivatives against Leishmania amazonensis. Mem. Inst. Oswaldo Cruz 94 (1999) 791-794
10. Bancroft J.D., and Stevens A. Theory and Practice of Histological Techniques (1982), Churchill Livingstone, London, New York
11. Barthelemy S., Vergnes L., Moynier M., Guyot D., Labidalle S., and Bahraoui E. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res. Virol. 149 (1998) 43-52
12. Baykal-Erkilic A., Erkilic E., Erkilic M., and Özden T. The effect of streptozotocin-induced diabetes on renal plasma flow. Exp. Clin. Endocrinol. 103 (1995) 367-372
13. Bergmeyer H.U., Scheibe P., and Wahlefeld A.W. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem. 24 (1978) 58-73
14. Bergquist N.R. Schistosomiasis, from risk assessment to control. Trends Parasitol. 18 (2002) 309-314
15. Bhaumik S., Jyothi M.D., and Khar A. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 483 (2000) 78-82
16. Bhavani Sankar T.N., and Murthy S. Effect of Turmeric (Curcuma longa) fractions on the growth of some intestinal and pathogenic bacteria in vitro. Indian J. Exp. Biol. 17 (1979) 1363-1366
17. Boros D.L. Immunopathology of Schistosoma mansoni infection. Clin. Microbiol. 2 (1989) 250-269
18. Brindley P.J. Drug resistance to schistosomicides and other anthelmintics of medical significance. Acta Trop. 56 (1994) 213-231
19. Brouet I., and Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206 (1995) 533-540
20. Bruce, J.I., Radke, M.G., 1971. Culturing Biomphalaria and Oncomelania (Gastropoda) for large-scale studies of schistosomiasis, I. Cultivation of Biomphalaria glabrata and maintenance of Schistosoma mansoni in the laboratory. Bio-medical Report 406th Medical Laboratory, vol. 19, pp. 1-84.
21. Bruck R., Ashkenazi M., Weiss S., Goldiner I., Shapiro H., Aeed H., Genina O., Helpern Z., and Pines M. Prevention of liver cirrhosis in rats by curcumin. Liver Int. 27 (2007) 373-383
22. Brunet L.R., Finkelman F.D., Cheever A.W., Kopf M.A., and Pearce E.J. IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159 (1997) 777-785
23. Brunet L.R., Dunne D.W., and Pearce E.J. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol. Today 14 (1998) 422-427
24. Buescher R., and Yang L. Turmeric. In: Lauro G.J., and Francis F.J. (Eds). Natural Food Colorants (2000), Marcel Dekker, New York 205-226
25. Capron M., and Capron A. Immunoglobulin E and effector cells in schistosomiasis. Science 264 (1994) 1876-1877
26. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin, a component of turmeric (Curcumin longa). J. Altern. Complement. Med. 9 (2003) 161-168
27. Chan M.M. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49 (1995) 1551-1556
28. Chan M.M., Huang H.I., Fenton M.R., and Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem. Pharmacol. 55 (1998) 1955-1962
29. Chatterjee S., Mbaye A., De Man J.G., and Van Marck E.A. Does the neuropeptide somatostatin have therapeutic potential against schistosomiasis?. Trends Parasitol. 18 (2002) 295-298
30. Cheever A.W. Condition affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull. World Health Org. 39 (1968) 328-331
31. Cheever A.W. Quantitative comparison of the intensity of Schistosoma mansoni infections in man and experimental animals. Trans. R. Soc. Trop. Med. Hyg. 63 (1969) 781-795
32. Cheever A.W., and Yap G.S. Immunologic basis of disease and disease regulation in schistosomiasis. Chem. Immunol. 66 (1997) 159-176
33. Cheever A.W., Williams M.E., Wynn T.A., Finkelman F.D., Seder R.A., Cox T.M., Hieny S., Caspar P., and Sher A. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 153 (1994) 753-759
34. Chopra R.N., Gupta J.C., and Chopra G.S. Pharmacological action of the essential oil of Curcuma longa. Indian J. Med. Res. 29 (1941) 769-772
35. Churchill M., Chadburn A., Bilinski R.T., and Bertagnolli M.M. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J. Surg. Res. 89 (2000) 169-175
36. Cioli D. Chemotherapy of schistosomiasis, an update. Parasitol. Today 14 (1998) 418-422
37. Cioli D., Pica-Mattoccia L., and Archer S. Drug resistance in schistosomes. Parasitol. Today 9 (1993) 162-166
38. Cipriani B., Borsellino G., Knowles H., Tramonti D., Cavaliere F., Bernardi G., Battistini L., and Brosnan C.F. Curcumin inhibits activation of Vγ 9Vδ2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J. Immunol. 167 (2001) 3454-3462
39. Cohen G., Dembiec D., and Marcus J. Measurement of catalase activity in tissues extracts. Ann. Biochem. 34 (1970) 30-38
40. Czaja M.J., Weiner F.R., Takahashi S., Giambrone M.A., van der Meide P.H., Schellekens H., Biempica L., and Zern M.A. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10 (1989) 795-800
41. Dacie S.J., and Lewis S.M. Practical Haematology. seventh ed. (1991), Churchill Livingstone
42. Davies S.J., Lim K.C., Blank R.B., Kim J.-H., Lucas K.D., Hernandez D.C., Sedgwick J.D., and McKerrow J.H. Involvement of TNF in limiting liver pathology and promoting parasite survival during schistosome infection. Int. J. Parasitol. 34 (2004) 27-36
43. Delgado V., and McLaren D.J. Evidence for enhanced of IgG1 subclass expression in mice polyvaccinated with radiation attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity. Parasite Immunol. 12 (1990) 15-32
44. Devasena T., Rajasekaran K.N., Gunasekaran G., Viswanathan P., and Menon V.P. Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacol. Res. 47 (2003) 133-140
45. Dohare P., Garg P., Jain V., Nath C., and Ray M. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav. Brain Res. 21 (2008) 289-297
46. Dunne D., and Mountford A. Resistance to infection in humans and animal models. In: Mahmoud (Ed). Schistosomiasis (2001), Imperial College Press, London, UK 133-212
47. Duvall R.H., and DeWitt W.B. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am. J. Trop. Med. Hyg. 16 (1967) 483-486
48. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., Dicato M., and Diederich M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 223 (2005) 181-190
49. El Ridi R. Toward a complete immunity-inducing vaccine for schistosomiasis. J. Parasitol. 88 (2002) 1049-1050
50. Fallon P.G., and Doenhoff M.J. Drug-resistant schistosomiasis, resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51 (1994) 83-88
51. Fennell C.W., Lindsey K.L., McGaw L.J., Sparg S.G., Stafford G.I., Elgorashi E.E., Grace O.M., and van Staden J. Assessing African medicinal plants for efficacy and safety, pharmacological screening and toxicology. J. Ethnopharmacol. 94 (2004) 205-217
52. Finkelman F.D., Holme J., Katona I.M., Vrban J.E., Beckman M.P., Park L.S., Schooly K.A., Coffman R.L., Mosmann T.R., and Paul W.E. Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 8 (1990) 303-334
53. Gaddipati J.P., Sundar S.V., Calemine J., Seth P., Sidhu G.S., and Maheshwari R.K. Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19 (2003) 150-156
54. Gao X., Kuo J., Jiang H., Deeb D., Liu Y., Divine G., Chapman R.A., Dulchavsky S.A., and Gautam S.C. Immunomodulatory activity of curcumin, suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem. Pharmacol. 68 (2004) 51-61
55. Grandjean-Laquerriere A., Gangloff S.C., Le Naour R., Trentesaux C., Hornebeck W., and Guenounou M. Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18 (2002) 168-177
56. Gryseels B. Schistosomiasis vaccines, a devils advocate view. Parasitol. Today 16 (2000) 46-48
57. Grzych J.-M., Pearce E., Cheever A., Caulada Z.A., Caspar P., Heiny S., Lewis F., and Sher A. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistomiasis mansoni. J. Immunol. 146 (1991) 1322-1327
58. Gulcubuk A., Altunatmaz K., Sonmez K., Haktanir-Yatkin D., Uzun H., Gurel A., and Aydin S. Effects of curcumin on tumour necrosis factor-α and interleukin-6 in the late phase of experimental acute pancreatitis. J. Vet. Med. A Physiol. Pathol. Clin. Med. 53 (2006) 49-54
59. Gupta B., and Ghosh B. Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int. J. Immunopharmacol. 21 (1999) 745-757
60. Hammond J.A., Fielding D., and Bishop S.C. Prospects for plant anthelmintics in tropical veterinary medicine. Vet. Res. Commun. 21 (1997) 213-228
61. Hernandez H.J., Wang Y., Tzellas N., and Stadecker M.J. Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur. J. Immunol. 27 (1997) 1170-1176
62. Hoffmann K.F., James S.L., Cheever A.W., and Wynn T.A. Studies with double cytokines-deficient mice reveal that highly polarized Th1 and Th2 type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J. Immunol. 163 (1999) 927-938
63. Hoffmann K.F., Cheever A.W., and Wynn T.A. IL-10 and the dangers of immune polarization, excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164 (2000) 6406-6416
64. Hu W., Brindley P.J., McManus D.P., Feng Z., and Han Z. Schistosome transcriptomes, new insights into the parasite and schistosomiasis. Trends Mol. Med. 10 (2004) 217-225
65. Huang H.-Q., Li S.-C., Qin Z.-H., Cao S.-L., Yao Y., Liu Y.-S., Li H.-Y., Cai M.-S., Li Z.-J., and Shi Y.-E. Synthesis and bioactivities of two multiple antigen peptides as potential vaccine against Schistosoma. Bioorganic Med. Chem. Lett. 15 (2005) 2415-2419
66. Iacomini J., Ricklan D.E., and Stadecker M.J. T cells expressing the gamma delta T cell receptor are not required for egg granuloma formation in schistosomiasis. Eur. J. Immunol. 25 (1995) 884-888
67. Inoue M. Protective mechanisms against reactive oxygen species. In: Arias I.M., Boyer J.L., Fausto N., Jakoby W.B., Schachter D.A., and Shafritz D.A. (Eds). The Liver: Biology and Pathobiology (1994), Raven Press, New York, USA 443-459
68. Iqbal M., Sharma S.D., Okazaki Y., Fujisawa M., and Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice, possible role in protection against chemical carcinogenesis and toxicity. Pharmacol. Toxicol. 92 (2003) 33-38
69. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., Day T.A., and Bennett J.L. Resistance to praziquantel, direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60 (1999) 932-935
70. Jagetia G.C., and Aggarwal B.B. "Spicing up" of the immune system by curcumin. J. Clin. Immunol. 27 (2007) 19-35
71. James S.L., Skamene E., and Meltzer M.S. Macrophages as effector cells of protective immunity in murine schistosomiasis. V: variation in macrophage schistosomulicidal and tumoricidal activities among mouse strain and correlation with resistance to re-infection. J. Immunol. 131 (1983) 948-953
72. James S.L., Natovitz P.C., Farrar W.L., and Leonard E.J. Macrophages as effector cells of murine schistosomiasis, macrophage activation in mice vaccinated with radiation-attenuated cercariae. Infect. Immun. 44 (1984) 569-575
73. Jankovic D., Wynn T.A., Kullberg M.C., Hieny S., Caspar P., James S., Cheever A.W., and Sher A. Optimal vaccination against Schistosoma mansoni requires the induction of both B cells and IFN-gamma-dependent effector mechanisms. J. Immunol. 162 (1999) 345-351
74. Joe B., Vijaykumar M., and Lokesh B.R. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44 (2004) 97-111
75. Jordan W.C., and Drew C.R. Curcumin, a natural herb with anti-HIV activity. J. Natl. Med. Assoc. 88 (1996) 333
76. Joseph A.L., and Boros D.L. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J. Immunol. 151 (1993) 5461-5471
77. Kang B.Y., Chung S.W., Chung W., Im S., Hwang S.Y., and Kim T.S. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur. J. Pharmacol. 384 (1999) 191-195
78. Kang B.Y., Song Y.J., Kim K.M., Choe Y.K., Hwang S.Y., and Kim T.S. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br. J. Pharmacol. 128 (1999) 380-384
79. Karsenty G., and Park R.W. Regulation of type I collagen genes expression. Int. Rev. Immunol. 12 (1995) 177-185
80. Kaviratne M., Hesse M., Leusink M., Cheever A.W., Davies S.J., McKerrow J.H., Wakefield L.M., Letterio J.J., and Wynn T.A. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent. J. Immunol. 173 (2004) 4020-4029
81. Kim G.Y., Kim K.H., Lee S.H., Yoon M.S., Lee H.J., Moon D.O., Lee C.M., Ahn S.C., Park Y.C., and Park Y.M. Curcumin inhibits immunostimulatory function of dendritic cells, MAPKs and translocation of NF-kappa B as potential targets. J. Immunol. 174 (2005) 8116-8124
82. King C.L., Malhotra I., and Tia X. Schistosoma mansoni, protective immunity in IL-4-deficient mice. Exp. Parasitol. 84 (1996) 245-252
83. Kiuchi F., Goto Y., Sugimoto N., Akao N., Kondo K., and Tsuda Y. Nematocidal activity of turmeric, synergistic action of curcuminoids. Chem. Pharm. Bull. 41 (1993) 1640-1643
84. Kobayashi T., Hashimoto S., and Horie T. Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem. Pharmacol. 54 (1997) 819-824
85. Koide T., Nose M., Ogihara Y., Yabu Y., and Ohta N. Leishmanicidal effect of curcumin in vitro. Biol. Pharm. Bull. 25 (2002) 131-133
86. Kumar A., Dhawan S., Hardegen N.J., and Aggarwal B.B. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem. Pharmacol. 55 (1998) 775-783
87. Kuramoto Y., Yamada K., Tsuruta O., and Sugano M. Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. Biosci. Biotechnol. Biochem. 60 (1996) 1712-1713
88. La Flamme A.C., Patton E.A., Bauman B., and Pearce E.J. IL-4 plays a crucial role in regulating oxidative damage in liver during Schistosomiasis. J. Immunol. 166 (2001) 1903-1911
89. Lammie P.J., Fenwick A., and Utzinger J. A blueprint for success, integration of neglected tropical disease control programmes. Trends Parasitol. 22 (2006) 313-321
90. Lantz R.C., Chena G.J., Solyomb A.M., Jolad S.D., and Timmermann B.N. The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12 (2005) 445-452
91. Leclercq I.A., Farrell C.C., Sempoux C., Pena A.D., and Horsmans Y.V. Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice. J. Hepatol. 41 (2004) 926-934
92. Lee J.H., Kim J.W., Ko N.Y., et al. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J. Allergy Clin. Immunol. 121 (2008) 1225-1231
93. Lee J.J., Huang W.T., Shao D.Z., Liao J.F., and Lin M.T. Blocking NF kappa B activation may be an effective strategy in the fever therapy. Jpn. J. Physiol. 53 (2003) 367-375
94. Leptak C.L., and McKerrow J.H. Schistosome egg granulomas and hepatic expression of TNF-alpha are dependent on immune priming during parasite maturation. J. Immunol. 158 (1997) 301-307
95. Li X., and Liu X. Effect of curcumin on immune function of mice. J. Huazhong University Sci. Technol. Med. Sci. 25 (2005) 137-140
96. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin-Phenol reagent. J. Biol. Chem. 193 (1951) 265-275
97. Mahmoud A.A.F., and Warren K.S. Anti-inflammatory effects of tarteremetic and niridazole suppression of Schistosoma egg granuloma. J. Immunol. 112 (1974) 222-228
98. Mangold B.L., and Dean D.A. Passive transfer with serum and IgG antibodies with irradiated cercariae-induced resistance against Schistosomiasis mansoni in mice. J. Immunol. 136 (1986) 2644-2647
99. Marques H.H., Zouain C.S., Torres C.B., Oliveira J.S., Alves J.B., and Goes A.M. Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni. Immunobiology 213 (2008) 437-446
100. Moon D.-O., Kim M.-O., Lee H.-J., Choi Y.H., Park Y.-M., Heo M.-S., and Kim G.-Y. Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. Biochem. Biophys. Res. Commun. 17 (2008) 275-279
101. Mukhopadhyay A., Banerjee S., Stafford L.J., Xia C., Liu M., and Aggarwal B.B. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21 (2002) 8852-8861
102. Neuman R.E., and Logan M.A. The determination of collagen and elastin in tissues. J. Biol. Chem. 186 (1950) 549-556
103. Neuman R.E., and Logan M.A. The determination of hydroxyproline. J. Biol. Chem. 184 (1950) 299-300
104. Nose M., Koide T., Ogihara Y., Yabu Y., and Ohta N. Trypanocidal effects of curcumin in vitro. Biol. Pharm. Bull. 21 (1998) 643-645
105. Ohmae H., Tanaka M., Nara T., Utsunomiyn H., Tagucchi H., Irhey Y., and Yasuraoka K. Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection. Am. J. Trop. Med. Hyg. 45 (1991) 350-359
106. Osman A., Allam G., and Saad A.-H. In vivo modulation of granuloma formation in mice infected with Schistosoma mansoni after treatment with vasoactive intestinal peptide (VIP). J. Egypt. Ger. Soc. Zool. 23 (1997) 113-135
107. Pan M.H., Huang T.M., and Lin J.K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 27 (1999) 486-494
108. Pearce E.J., Caspar P., Grzych J.M., Lewis F.A., and Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med. 173 (1991) 159-166
109. Ranjan D., Johnston T.D., Wu G., Elliott L., Bondada S., and Nagabhushan M. Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. J. Surg. Res. 77 (1998) 174-178
110. Ranjan D., Siquijor A., Johnston T.D., Wu G., and Nagabhuskahn M. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. Am. Surg. 64 (1998) 47-51
111. Ranjan D., Chen C., Johnston T.D., Jeon H., and Nagabhushan M. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NF-κB activation, and IL-2 signaling. J. Surg. Res. 121 (2004) 171-177
112. Rasmussen H.B., Christensen S.B., Kvist L.P., and Karazmi A. A simple and efficient separation of the curcumins, the antiprotozoal constituents of Curcuma longa. Planta Med. 66 (2000) 396-398
113. Reddy R.C., Vatsala P.G., Keshamouni V.G., Padmanaban G., and Rangarajan P.M. Curcumin for malaria therapy. Biochem. Biophys. Res. Commun. 326 (2005) 472-474
114. Renard P., Delaive E., Van Steenbrugge M., Remacle J., and Raes M. Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-κB activation?. Antioxid. Redox. Signal 3 (2001) 329-340
115. Ritter D., and McKerrow J. Intercellular adhesion molecule 1 is the major adhesion molecule expressed during schistosome granuloma formation. Infect. Immun. 64 (1996) 4706-4713
116. Salvioli L., Renganathan E., Montresor A., Davis A., and Behbehani K. Control of schistosomiasis-a global picture. Parasitol. Today 13 (1997) 444-448
117. Sanderson L., Bartlett A., and Whitfield P.J. In vitro and in vivo studies on the bioactivity of a ginger (Zingiber officinale) extract towards adult schistosomes and their egg production. J. Helminthol. 76 (2002) 241-247
118. Santibanez J.F., Quintanilla M., and Martinez J. Genistein and curcumin block TGF-beta1-induced u-PA expression and migratory and invasive phenotype in mouse epidermal keratinocytes. Nutr. Cancer 37 (2000) 49-54
119. Schubert M. Conditions for drug testing in experimental Schistosomiasis mansoni in mice. Am. J. Trop. Med. 28 (1948) 121-136
120. Secor W.E., Stewart S.J., and Colley D.G. Eosinophils and immune mechanisms. VI: The synergistic combination of granulocyte-macrophage colony-stimulating factor and IL-5 accounts for eosinophil-stimulation promoter activity in Schistosoma mansoni-infected mice. J. Immunol. 144 (1990) 1484-1489
121. Sharma R.A., Ireson C.R., Verschoyle R.D., et al. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa, relationship with drug levels. Clin. Cancer Res. 7 (2001) 1452-1458
122. Sharma S., Chopra K., Kulkarni S.K., and Agrewala J.N. Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin. Exp. Immunol. 147 (2007) 155-163
123. Sher A., Coffman R.L., Hieny S., Scott P., and Cheever A.W. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc. Natl. Acad. Sci. USA 87 (1990) 61-65
124. Sher A., Fiorentino D., Caspar P., Pearce E., and Mosmann T. Production of IL-10 by CD4-T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147 (1991) 2713-2716
125. Siddiqui A.M., Cui X., Wu R., Dong W., Zhou M., Hu M., Simms H.H., and Wang P. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ. Crit. Care Med. 34 (2006) 1874-1882
126. Srinivasan A., and Menon V.P. Protection of pancreatic β-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J. Pharm. Pharm. Sci. 6 (2003) 327-333
127. Steinmann P., Keiser J., Bos R., Tanner M., and Utzinger J. Schistosomiasis and water resources development, systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6 (2006) 411-425
128. Stelma F.F., Talla I., Sow S., Kongs A., Niang M., Polman K., Deelder A.M., and Gryseels B. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53 (1995) 167-170
129. Stirewalt M.A., and Bronson J.F. Description of plastic mouse restraining case. J. Parasitol. 41 (1955) 328
130. Terry C.M., Clikeman J.A., Hoidal J.R., and Callahan K.S. Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 274 (1998) 883-891
131. Tietz N. Fundamental of Clinical Chemistry (1986), W.B. Founders Saunders Co., Philadelphia
132. Tietz N. Clinical Guide to Laboratory Tests. second ed (1991), Saunders Company, London
133. Vaillant B., Chiaramonte M.G., Cheever A.W., Soloway P.D., and Wynn T.A. Regulation of hepatic fibrosis and extracellular matrix genes by the response, new insight into the role of tissue inhibitors of matrix metalloproteinases. J. Immunol. 167 (2001) 7017-7026
134. Vella A.T., and Pearce E.J. CD4 Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J. Immunol. 148 (1992) 2283-2290
135. Wang X., Wang Q., Ives K.L., and Ever B.M. Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin. Cancer Res. 12 (2006) 5346-5355
136. Warren K.S., Domingo E.O., and Cowan R.B.T. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am. J. Pathol. 51 (1967) 735-756
137. Wei Q.-Y., Chen W.-F., Zhou B., Yang L., and Liu Z.-L. Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim. Biophys. Acta 1760 (2006) 70-77
138. WHO, 1997. Schistosomiasis. Fact sheet no. 115. Geneva, WHO.
139. Woo H.-M., Kang J.-H., Kawada T., Yoo H., Sung M.-K., and Yu R. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 80 (2007) 926-931
140. Wynn T.A., Eltoum I., Cheever A.W., Lewis F.A., Gause W.C., and Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151 (1993) 1430-1440
141. Wynn T.A., Cheever A.W., Jankovic D., Poindexter R.W., Caspar P., Lewis F.A., and Sher A. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376 (1995) 594-596
142. Wynn T.A., Cheever A.W., Williams M.E., Hieny S., Caspar P., Kuhn R., Muller W., et al. IL-10 regulates liver pathology in acute murine schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J. Immunol. 160 (1998) 4473-4480
143. Yadav V.S., Mishra K.P., Singh D.P., Mehrotra S., and Singh V.K. Immunomodulatory effects of curcumin. Immunopharmacol. Immunotoxicol. 27 (2005) 485-497
144. Young D.S. Effects of Drugs on Clinical Laboratory Tests (1995), AACC Press
145. Zhang M., Deng C.S., Zheng J.J., and Xia J. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis. Acta Pharmacol. Sin. 27 (2006) 1071-1077